Manna, A., Aulakh, S., Jani, P., Ahmed, S., Akhtar, S., Coignet, M., . . . Paulus, A. (2019). Targeting CD38 enhances the antileukemic activity of ibrutinib in chronic lymphocytic leukemia (CLL). Clin Cancer Res.
Style de citation ChicagoManna, Alak, et al. "Targeting CD38 Enhances the Antileukemic Activity of Ibrutinib in Chronic Lymphocytic Leukemia (CLL)." Clin Cancer Res 2019.
Style de citation MLAManna, Alak, et al. "Targeting CD38 Enhances the Antileukemic Activity of Ibrutinib in Chronic Lymphocytic Leukemia (CLL)." Clin Cancer Res 2019.
Attention : ces citations peuvent ne pas être correctes à 100%.